GlassScriptPhysician profile
Aashish Jay Kumar
NPI 1356769194
$160,129.64
in general payments reported to CMS, 2019-2025
40 companies · $38K in 2025
The $38K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,963 · 2020: $1,342 · 2021: $6,270 · 2022: $43K · 2023: $40K · 2024: $28K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Travel and Lodging: $30K · Food and Beverage: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Honoraria: $508 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,939.45 |
| Travel and Lodging | $29,998.50 |
| Food and Beverage | $14,968.70 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,707.50 |
| Honoraria | $508.00 |
| Education | $159.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $88,421.74 | 2020-2025 | Sprint Pns System |
| Bioventus LLC | $28,391.18 | 2022-2025 | Stimrouter Implantable Kit, Stimrouter Implantable Kit, Xcell |
| Vertex Pharmaceuticals Incorporated | $11,980.48 | 2024-2025 | |
| Abbott Laboratories | $9,770.47 | 2021-2025 | Proclaim, Eterna, Octrode |
| Redhill Biopharma INC. | $3,932.89 | 2021 | |
| Medtronic, INC. | $3,439.03 | 2021-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Boston Scientific Corporation | $3,230.25 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $2,910.02 | 2019-2024 | Senza |
| Saluda Medical Americas, INC. | $2,876.96 | 2023-2024 | Evoke Scs, Evoke |
| Medtronic USA, INC. | $903.48 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $523.24 | 2023 | Exparel, Zilretta, Iovera |
| Zoll Medical Corporation | $516.67 | 2022 | |
| Becton, Dickinson and Company | $458.33 | 2022 | |
| Collegium Pharmaceutical, INC. | $433.57 | 2021-2025 | Xtampza, Belbuca |
| Baxter Healthcare | $400.00 | 2020 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $375.86 | 2023-2024 | Painteq |
| Nalu Medical, INC. | $297.30 | 2021-2025 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $245.65 | 2023-2025 | Prospera, Biotronik |
| Pfizer INC. | $129.01 | 2019-2025 | |
| Merz Pharmaceuticals, LLC | $104.23 | 2024-2025 | Xeomin |
| Abbvie INC. | $94.41 | 2022 | |
| Ibsa Pharma INC. | $73.33 | 2022-2025 | Licart, Tirosint, Tirosint |
| Grt US Holding, INC. | $70.89 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.43 | 2024 | Relistor |
| Allergan, INC. | $61.70 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $61.23 | 2022-2023 | Seglentis |
| Scilex Pharmaceuticals INC. | $61.05 | 2024-2025 | |
| Averitas Pharma INC. | $43.57 | 2023-2025 | Qutenza |
| Curonix LLC | $36.20 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Tonix Medicines, INC. | $31.56 | 2025 | Tonmya |
| Indivior INC. | $25.65 | 2025 | Sublocade |
| Pacira Therapeutics, INC. | $23.20 | 2019 | |
| Si-Bone, INC. | $23.12 | 2024 | |
| Electronic Waveform Lab, INC. | $19.68 | 2024 | |
| Vertos Medical, INC. | $18.85 | 2024 | Mild Device Kit |
| Mml US, INC. | $18.13 | 2023 | Reactiv8 |
| Valinor Pharma, LLC | $17.81 | 2025 | Movantik |
| Relievant Medsystems, INC. | $17.28 | 2023 | Intracept |
| Azurity Pharmaceuticals, INC. | $14.29 | 2024 | Horizant |
| International Rehabilitative Sciences, INC | $13.90 | 2024 | Rs-4i Plus Sequential Stimulator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aashish Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.